Delivery Order SPE2DR25D2014-SPE2DR26FZ71R
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,597.60 by the Defense Logistics Agency on November 4, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of November 5, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp received a $12,823.56 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 3, 2025, for HUMIRA (CF) Pen 40 mg/0.4 mls pharmaceutical products, with completion targeted for September 4, 2025. This non-set-aside contract will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a competitive award to the established pharmaceutical distributor, which maintains significant federal...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 22, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mls, a biologic medication used to treat inflammatory conditions. This is a firm fixed-price delivery order with a ceiling value of $4,531.80 and an ultimate completion date of May 23, 2025. The contract is non-competitive with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for $1,132.95 to supply HUMIRA (CF) Pen 40 mg/0.4 mls, a brand-name pharmaceutical product used in the treatment of autoimmune conditions. The contract is a firm fixed-price delivery order with an ultimate completion date of June 6, 2025, and was competitively awarded without set-aside designation. This award is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $14,765.41 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical products. This is a firm fixed price, non-set-aside contract with a completion date of August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HUMIRA (Pen) 40 mg/0.4 mls with a ceiling value of $2,265.90. This competitive award, issued on October 30, 2025, with an ultimate completion date of October 31, 2025, represents a firm fixed price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,132.95 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this contract. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $17,422.25 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in treating inflammatory conditions. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 4, 2025, and performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under a larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $14,127.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, with an ultimate completion date of September 23, 2025. This is a non-set-aside contract issued to the Corporate Office division of the company, headquartered in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical procurement under AmerisourceBergen's larger federal contract portfolio with the Defense Logistics...
- AmerisourceBergen Drug Corp was awarded a $30,792.85 delivery order contract for HUMIRA Pen 40mg/4mL (2-pack units) under a firm fixed-price arrangement with an ultimate completion date of September 4, 2025. This competitively awarded, non-set-aside delivery order is issued by the Defense Logistics Agency's Medical Supply Chain, which procures pharmaceutical and medical products to support the Department of Defense's healthcare operations, including military treatment facilities and the...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ71RDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $20,325.24 by the Defense Logistics Agency on November 17, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by November 18, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement designated as SPE2DX that extends through December 2026 and serves as the primary vehicle for global pharmaceutical support to military healthcare programs. The Defense Logistics Agency, operating under the Department of Defense, procures pharmaceuticals and medical supplies to support military healthcare operations worldwide. AmerisourceBergen's role as a pharmaceutical prime vendor under the SPE2DX contract enables it to supply brand-name and generic medications, specialty drugs, vaccines, and related medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This particular delivery order represents one of numerous competitive awards issued against the comprehensive IDC, reflecting the vendor's established capability to meet federal procurement requirements for critical pharmaceutical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.3k | 11/17/25 |